Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
MARKETS

Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals & Drugs

| BSE 177.60 0.60 (0.34%) | |

BSE Live

Feb 20, 16:01
177.60 0.60 (0.34%)
Volume
AVERAGE VOLUME
5-Day
22,866
10-Day
34,448
30-Day
42,659
14,866

  • Prev. Close

    177.00

  • Open Price

    170.05

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 20, 15:58
178.38 1.48 (0.84%)
Volume
AVERAGE VOLUME
5-Day
448,580
10-Day
646,385
30-Day
801,366
438,131

  • Prev. Close

    176.90

  • Open Price

    176.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    178.38 (1251)

Financials

Cash Flow of Marksans Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 52.73 56.01 16.65 11.95 91.63  
Net CashFlow From Operating Activities 118.01 19.81 15.63 -13.62 64.76  
Net Cash Used In Investing Activities -24.10 -20.20 -7.55 -7.69 -177.34  
Net Cash Used From Financing Activities -92.29 0.96 -9.98 20.74 -51.83  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 1.63 0.56 -1.90 -0.57 -164.41  
Cash And Cash Equivalents Begin of Year 1.12 0.55 2.45 3.13 167.54  
Cash And Cash Equivalents End Of Year 2.75 1.12 0.55 2.56 3.13  
Source : Dion Global Solutions Limited

Results of Marksans Pharma

  • 01.01.1970

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026